Friday, September 30, 2016



The Impact of Androgen Deprivation on One-year Mortality in a Large Prostate Cancer Registry with Cardiovascular Risk Factors

Presenting Author: Dr. Kristopher Swiger, Vanderbilt University Medical Center, Nashville, TN, USA



Understanding Cardiac Issues in Multiple Myeloma patients: An ongoing Prospective Observation of Cardiac Safety with Proteasome Inhibition (PROTECT) study

Presenting Author: Dr. Trafina Jadhav, Division of Cardiology, Vanderbilt University Medical Center, Nashville, TN, USA



Cardiac symptoms, signs, new cardiac medication and left ventricular ejection fraction (LVEF) changes with 6 versus 12 months adjuvant trastuzumab: 2,500 patients in the Persephone Trial

Presenting Author: Prof. Helena Earl, Department of Oncology, University of Cambridge, Addenbrooke’s Hospital, Cambridge, Cambridgeshire, UK



Thursday, September 29, 2016



Cardiovascular Events After exposure to Nilotinib in Chronic Myeloid Leukemia: A Single Institution Study, Long term follow up.

Presenting Author: Dr. Nazanin Aghel, Division of Cardiology, University Health Network, University of Toronto, Toronto, ON, Canada



Use of Entresto (sucubitril/valsartan) in Anthracycline Induced Cardiomyopathy

Presenting Author: Maria Anwar, South Health Campus, Alberta Health Services, Calgary, AB, Canada



Incidence and outcomes of chemotherapy-induced cardiomyopathy patients among referrals for advanced heart failure

Presenting Author: Dr. Raquel Araujo-Gutierrez, Houston Methodist Research Institute, Houston, TX, USA



The influence of exercise training on indices of autonomic nervous system function among women undergoing paclitaxel chemotherapy for breast cancer

Presenting Author: Kelcey Bland, Rehabilitation Sciences, University of British Columbia, Vancouver, BC, Canada



Cardiovascular complications of ibrutinib: a systematic review and meta-analysis

Presenting Author: Dr. Francois Caron, Population Health Research Institute, Hamilton, ON, Canada



Chemotherapy Treatment with either Panitumumab or Vinorelbine Increases the Risk of Developing Atrial Fibrillation in Lung Cancer

Presenting Author: Dr. Brandon Chalazan, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA



Effect of Remote Ischaemic Conditioning in ONCology patients undergoing chemotherapy: Background and study design of the ERIC-ONC study

Presenting Author: Dr. Robin Chung, University College London, Hatter Cardiovascular Institute, London, UK



Cardiac complications after bone marrow transplantation: incidence of disease and associated risk factors

Presenting Author: Dr. Jose David Chuquin, Virginia Commonwealth University Medical Center, Richmond, VA, USA



Building a targeted approach to assessing risk of anthracycline induced cardiomyopathy

Presenting Author: Dr. Rachel Conyers, Children’s Cancer Center, The Royal Children’s Hospital, Melbourne, Victoria, Australia



The role of 2D-Transthoracic Echocardiography in patients with Multiple Myeloma

Presenting Author: Dr. Sorin Danciu, Advocate Illinois Masonic Medical Center, Chicago, IL, USA 



Cancer-related cardiac toxicities: Psychological correlates

Presenting Author: Dr. Susan Dent, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada



Detection of apoptosis and relationship to ventricular function in patients with early stage breast cancer receiving anthracycline-based chemotherapy

Presenting Author: Dr. Susan Dent, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada



Assessment of LVEF by CMR versus MUGA in Breast Cancer Patients Receiving Trastuzumab: A Blinded Prospective Observational Pilot Study

Presenting Author: Vinita Dhir, Division of Hematology/Oncology, St. Michael’s Hospital, Toronto, ON, Canada



Electrocardiographic Changes Associated with Ibrutinib Use

Presenting Author: Dr. Michael Fradley, Lee Moffitt Cancer Center and Research Institute, University of South Florida, Morsani College of Medicine, Tampa, FL, USA



“It’s not just the chemo” – a case of exertional dyspnoea in a Hodgkin survivor

Presenting Author: Dr. Arjun Ghosh, Department of Cardiology, Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust, West Smithfield, London, UK



An evaluation of cardiovascular and oncologic outcomes associated with interruption vs. continuation of adjuvant trastuzumab following the development of mild left ventricular dysfunction

Presenting Author: Jordan Gibson, Vancouver Fraser Medical Program, University of British Columbia, Vancouver, BC, Canada



Real world experience of screening for cardiotoxicity in a major UK cancer center – what can we learn?

Presenting Author: Dr. Dionisio Izquierdo, Cardio-Oncology Service, Barts Heart Centre, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK 



Combined kinome and transcriptome profiling reveals broad and distinct activities of cardiosafe (erlotinib) and cardiotoxic (sunitinib, sorafenib) kinase inhibitors

Presenting Author: Dr. Brian Jensen, Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA



Early myocardial strain changes during potentially cardiotoxic chemotherapy may occur due to reductions in LV end diastolic volume in addition to systolic dysfunction: The need to interpret LV strain with volumes

Presenting Author: Dr. Jennifer Jordan, Department of Internal Medicine, Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA



Elevated myocardial extracellular volume (ECV) occurs independently of LVEF declines in pediatric cancer survivors

Presenting Author:  Dr. Jennifer Jordan, Department of Internal Medicine, Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA



Cardio-protection from a single exercise session performed 24 hours prior to doxorubicin treatment in breast cancer patients

Presenting Author:  Amy Kirkham, University of Alberta, Edmonton, AB, Canada



Opportunities for Analytical and Cognitive Technology Innovation in Cardiac Oncology

Presenting Author:  Marianna Krive, Division of Cardiology, Advocate Lutheran General Hospital, Park Ridge, Illinois, USA



Anthracycline Cardiotoxicity in Patients with Acute Myeloid Leukemia Undergoing Intensive Therapies: A pilot study of the evaluation of current standards in cardiovascular risk assessment, monitoring, and management

Presenting Author: Dr. Stella Kyung, Division of Cardiology, Stony Brook University Hospital, Stony Brook, NY, USA



Changes in global longitudinal strain according to BRCA1/2 mutation status in patients with history of breast cancer treated with anthracyclines

Presenting Author: Dr. Bryan LeBude, Division of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, DC, USA



Exercise Right Heart Catheterization for Pulmonary Hypertension Identified on Screening Echocardiography in Adult Survivors of Childhood Cancer: A report from the St. Jude Lifetime Cohort

Presenting Author: Dr. Daniel Lenihan, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN, USA



RADICAL PC: A Prospective Multicentre Study of Cardiovascular Disease in Men with Prostate Cancer

Presenting Author: Dr. Darryl Leong, The Population Health Research Institute, McMaster University and Hamilton Health Sciences, Toronto, ON, Canada



Adverse maternal cardiac and fetal outcomes in pregnant women with treated cancer

Presenting Author: Dr. Shiying Liu, Division of Cardiology, Department of Medicine, University Health Network, University of Toronto, Toronto, ON, Canada



Real-time optical mapping of acute mitochondrial dysfunction with chemotherapy agent doxorubicin in Langendorff-perfused rat hearts

Presenting Author: Dr. Alexander Lyon, Myocardiac Function, NHLI, Imperial College London, London, UK



Development of a Cardio-Oncology Service in the United Kingdom – a Report of 5 Year Experience

Presenting Author: Dr. Alexander Lyon, Myocardiac Function, NHLI, Imperial College London, London, UK



Hypoxic preconditioning protects adult cardiomyocytes from Doxorubicin-induced injury

Presenting Author:  Dr. Angshuman Maulik, Hatter Cardiovascular Institute, University College London, London, UK



Left ventricular end-diastolic volume mediated declines in ejection fraction after potentially cardiotoxic cancer treatment

Presenting Author: Dr. Giselle Melendez, Department of Internal Medicine, Section on Cardiovascular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA



Effects of Proteasome Inhibition on Vascular Function

Presenting Author: Dr. Arvind Pandey, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA



Characteristics of cancer patients and survivors undergoing transcatheter aortic valve replacement

Presenting Author: Dr. Aarti Patel, University of South Florida, Department of Cardiovascular Sciences, Tampa, FL, USA



Clinical characteristics of patients with cancer and acute coronary syndrome

Presenting Author: Dr. Grzegorz Piotrowski, Cardiology Department, Nicolaus Copernicus Memorial Hospital, Lodz, Poland



Establishing the Type of Cardiac Amyloidosis: A Clinical Challenge

Presenting Author: Dr. Karen Riggins, Vanderbilt University Medical Center, Nashville, TN, USA



Pathological Correlates and Outcomes from Treatment of Cardiac Light Chain (AL) Amyloidosis

Presenting Author: Alexandra Ritts, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA



Cardiac SAFEty of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function: SAFE-HEaRT

Presenting Author: Arielle Schwartz, Georgetown University School of Medicine, Washington, DC, USA



Identifying the Incidence of Trastuzumab-Induced Cardiotoxicity at a “Real World” Tertiary Care Centre

Presenting Author: Grace Tang, Division of Medical Oncology, St. Michael’s Hospital, Toronto, ON, Canada



Feasibility of Optimal Echocardiographic Myocardial Strain Imaging for Cancer Therapy Monitoring: the Community Health Network Experience

Presenting Author: Dr. Rey Vivo, Community Heart and Vascular Hospital, Indianapolis, IN, USA



Early changes in biomarkers of nitrosative stress are associated with doxorubicin and trastuzumab-induced cardiac dysfunction in breast cancer patients

Presenting Author: Dr. Teresa Wang, Division of Cardiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA      



Relationship between three-dimensional myocardial strain and non-contrast tissue mapping by cardiac magnetic resonance imaging in patients receiving anthracycline-based chemotherapy

Presenting Author: Dr. James White, Department of Diagnostic Imaging, University of Calgary, Calgary, AB, Canada



Identifying research-practice gaps for mapping research priorities in response to clinical cardiotoxicity induced by targeted anticancer therapeutics

Presenting Author: Dr. Ping-Pin Zheng, Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands



Sex-dependent Alteration of Cytochrome P450 Expression by Acute Doxorubicin Cardiotoxicity

Presenting Author: Dr. Beshay Zordoky, Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA